Riskpilot← Back to searchSign inGet full accessCamerix AB
ABActiveOrg 5591366793Vikingagatan 23Other non-specialised retail sale · NACE 4712Est. 20170 employees
Revenue 2024
SEK 6,2M
-18% vs 2023
EBITDA margin
5.2%
-71% vs 2023
Equity ratio
5.7%
Financial strength
Net profit 2024
SEK -12K
-102% vs 2023
| Revenue | SEK 6,2M | -18% |
| EBITDA | SEK 324K | -71% |
| Net profit | SEK -12K | -102% |
| Total assets | SEK 2,1M | +1% |
| Equity | SEK 118K | -84% |
| Employees | 0 | — |
Legal name
Camerix AB
Org number
5591366793
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
1 december 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva import av medicinska självtester samt försäljning av dessa.
Address
Vikingagatan 23
Email
kemimartin@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 383 | 5 440 | 8 005 | 7 574 | 6 200 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 148 | 497 | 1 460 | 1 116 | 324 |
| Depreciation & amort. | −8 | −8 | −8 | −8 | — |
| EBIT | 140 | 489 | 1 452 | 1 108 | 324 |
| Net financials | −1 | −1 | 1 | 1 | 4 |
| Profit before tax | 284 | 489 | 1 453 | 826 | −5 |
| Tax | −64 | −107 | −303 | −176 | −7 |
| Net profit | 220 | 382 | 1 150 | 650 | −12 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 076 | 1 414 | 2 224 | 2 059 | 2 077 |
| Equity | 499 | 631 | 1 281 | 731 | 118 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 394 | 600 | 760 | 863 | 1 958 |
| Total debt | 394 | 600 | 760 | 863 | 1 958 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20202024
Equity ratio
5.7%
This company
38.2%
Market median
-85% vs market
20202024
Return on equity
-10.5%
This company
18.4%
Market median
-157% vs market
20202024
Net profit margin
-0.2%
This company
8.1%
Market median
-102% vs market
20202024
Asset turnover
2.99×
This company
1.12×
Market median
+167% vs market
20202024
Debt / equity
16.58×
This company
0.62×
Market median
-2574% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tandläkare Cle AB
Camerix AB Board members of Camerix AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Håkan Malmqvist | Audit | 0 companies |
| Martin Niklas Erixon | Deputy Board Member | 0 companies |
| Lisbeth Caroline Erixon | Board of Directors | 0 companies |